IP Library Granted Patent US 11,753,507
Granted Patent B2
US 11,753,507 · App. 17/132,234 · Granted Sep 12, 2023

Addition curable composition comprising siloxane-imide copolymers

Inventors: Subrata Mandal (Bangalore, IN); Tetsuo Fujimoto (Gunma, JP); Vinodh Rajendra (Ballston Spa, NY); Joseph Zampella (Niskayuna, NY); Ramasubramanian Narayanan (Bangalore, IN); Clarissa Miller (Waterford, NY)
Assignee: Momentive Performance Materials Inc.
C08G77/455C08G77/08C08G77/12C08G77/20C08G77/70C08G77/80C08K3/22C08K5/3417C08L83/08C08K2003/2272C08L2201/08C08L2203/20C08L2205/03C08L2312/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,753,507
App. No.
17/132,234
Granted
Sep 12, 2023
Kind
B2
Abstract

A curable silicone adhesive composition comprising a heat stable siloxane-imide copolymer is shown and described herein. The composition includes an alkenyl silicone, a silicone hydride based cross linker, hydrosilylation catalyst and additives that is curable at relatively low temperatures and shows good heat stability.

Claims (68)

1. An addition curable silicone-imide composition comprising:

(A) an alkenyl functional siloxane-imide copolymer selected from a compound of the formula (I):

R 1 is independently selected from a C5-C20 aryl, a polycyclic aryl group comprising two or more C5-C20 aryl groups, where R 1 can be unsubstituted or substituted with a C1-C6 alkyl, a halogen, a haloalkyl, a hydroxy, and/or a C1-C5 alkoxy groups;

R 2 is independently selected from a C1-C20 divalent hydrocarbon, a C4-C20 branched divalent hydrocarbon, or a C4-C30 cyclic containing hydrocarbon group;

R 3 , R 4 , R 5 , and R 6 are each independently selected from a C1-C10 alkyl and a C6-C20 aryl;

m is an integer from 1 to about 200; and

n is an integer from 1 to about 30; the alkenyl functional siloxane-imide copolymer being present in the composition in an amount of from about 20 to about 50 parts by mass based on the total weight of the curable silicone composition;

(B) from about 20 parts to about 50 parts by mass of an alkenyl functional organosiloxane based on the total weight of the curable silicone composition;

(C) a polyorganohydrogensiloxane having at least two hydrogen atoms bonded to silicon atoms;

(D) a catalyst selected from precious metal catalysts selected from ruthenium, rhodium, palladium, osmium, iridium, and platinum, and complexes comprising one or more of such metals;

(E) an additive; and

(F) 0 parts by mass to about 3000 parts of a filler based on the total weight of the curable silicone composition.

2. The addition curable composition of claim 1 , wherein R 1 is independently selected from benzene, naphthalene, benzophenone, biphenyl, a biphenyl alkane, biphenylether, isopropylidinediphenylphenoxy, biphenyl sulfone, biphenyl sulfide, norbornyl, or hexafluoromethylbiphenyl.

3. The addition curable composition of claim 1 , wherein R 1 is benzene.

4. The addition curable composition of claim 1 , comprising the alkenyl functional siloxane-imide copolymer (A) in an amount of from about 10 parts by mass to about 100 parts based on total weight of the curable silicone-imide composition.

5. The addition curable composition of claim 1 , comprising the alkenyl functional siloxane-imide copolymer (A) in an amount of from about 30 parts to about 95 parts based on total weight of the curable silicone-imide composition.

6. The curable composition of claim 1 , comprising the alkenyl functional organosiloxane (B) which is selected from a compound of the formula M 1 a M 2 b D 1 c D 2 d T 1 e T 2 f Q g wherein:

M 1 =R 7 R 8 R 9 SiO 1/2

M 2 =R 10 R 11 R 12 SiO 1/2

D 1 =R 13 R 14 SiO 2/2

D 2 =R 15 R 16 SiO 2/2

T 1 =R 17 SiO 3/2

T 2 =R 18 SiO 3/2

Q=SiO 4/2

where R 7 , R 8 , R 9 , R 11 , R 12 , R 13 , R 14 , R 16 , and R 17 are independently chosen from a C1-C30 hydrocarbon, or a C6-C30 aromatic group;

R 10 , R 15 , and R 18 are independently chosen from a C1-C30 hydrocarbon, a C6-C30 aromatic group, C1-C30 alkoxy group, or a C2-C30 alkenyl group, with the proviso that one or more of R 10 , R 15 , and/or R 18 are selected from a C2-C30 alkenyl group;

the subscripts a, b, c, d, e, f, g, are zero or positive subject to the following limitations: 2<a+b+c+d+e+f+g<2000, and b+d+f>0.

7. The curable composition of claim 6 , wherein R 7 , R 8 , R 9 , R 11 , R 12 , R 13 , R 14 , R 16 , and R 17 are independently chosen from a C1-C30 hydrocarbon, or a C6-C30 aromatic group, where at least one of R 7 , R 8 , R 9 , R 11 , R 12 , R 13 , R 14 , R 16 , and R 17 is selected from a C6-C30 aromatic group.

8. The curable composition of claim 7 , wherein at least one of R 13 and/or R 14 is a C6-C30 aromatic group.

9. The curable composition of claim 8 , wherein R 13 and/or R 14 are a phenyl group.

10. The curable composition of claim 1 , comprising the alkenyl functional organosiloxane (B) in an amount of from about 10 parts by mass to about 50 parts based on the total weight of the curable silicone composition.

11. The curable composition of claim 1 , wherein the alkenyl functional siloxane-imide copolymer (A) is present in an amount of from about 30 parts to about 40 parts by mass based on total weight of the curable silicone-imide composition, and the alkenyl functional organosiloxane (B) is present in an amount of 30 parts to about 40 parts by mass based on total weight of the curable silicone-imide composition.

12. The curable composition of claim 1 , wherein the polyorganohydrogensiloxane (C) is chosen from a compound of the formula:

M 3 h M 4 i D 3 j D 4 k T 3 m T 4 n Q o

wherein:

M 3 =R 19 R 20 R 21 SiO 1/2

M 4 =R 22 R 23 R 24 SiO 1/2

D 3 =R 25 R 26 SiO 2/2

D 4 =R 27 R 28 SiO 2/2

T 3 =R 29 SiO 3/2

T 4 =R 30 SiO 3/2

Q=SiO 4/2

where R 19 , R 20 , R 21 , R 25 , R 26 , and R 29 , and are independently chosen from a C1-C30 hydrocarbon, a C6-C30 aromatic group, or C1-C30 alkoxy group;

R 22 , R 23 , R 24 , R 27 , R 28 , and R 30 are independently chosen from hydrogen, a C1-C30 hydrocarbon, a C6-C30 aromatic group, C1-C30 alkoxy group, or a C2-C30 alkenyl group, with the proviso that one or more of R 22 , R 23 , R 24 , R 27 , R 28 , and/or R 30 are hydrogen;

the subscripts h, i, j, k, m, n, o, are zero or positive subject to the following limitations: 1<h+i+j+k+m+n+o<100, i+k+n>0.

13. The curable composition of claim 1 , comprising the polyorganohydrogensiloxane (C) in an amount of from about 0.05 parts by mass to about 10 parts based on the total weight of the curable composition.

14. The curable composition of claim 1 , wherein the catalyst (D) is present in an amount of from about 1 parts by mass to about 10 parts based on the total weight of the curable silicone composition.

15. The curable composition of claim 1 , wherein the additive (E) is selected from at least one of a pigment, a lubricant, a viscosity modifier, a heat stabilizer, a photostabilizer, a flame retardant, an inhibitor, an adhesion promoter, or combinations of two or more thereof.

16. The curable composition of claim 1 , comprising the additive (E) in an amount of from about 0.05 parts by mass to about 3000 parts based on the total weight of the curable silicone composition.

17. The curable composition of claim 15 , wherein the additive is an inhibitor.

18. The curable composition of claim 17 , wherein the inhibitor is selected from an ethylenically unsaturated amide, aromatically unsaturated amide, an acetylenic compound, an ethylenically unsaturated isocyanate, an olefinic siloxane, an unsaturated hydrocarbon diester, an unsaturated hydrocarbon mono-ester of unsaturated acid, a conjugated or isolated ene-yne, a hydroperoxide, a ketone, a sulfoxide, an amine, a phosphine, a phosphite, a nitrite, a diaziridine, or a combination of two or more thereof.

19. The curable composition of claim 17 , wherein the inhibitor is selected from an alkynyl alcohol, a maleate, or a combination thereof.

20. The curable composition of claim 17 , wherein the inhibitor is selected from diallyl maleate, hydroquinone, p-methoxyphenol, t-butylcatechol, phenothiazine, or a combination of two or more thereof.

21. The curable composition of claim 17 , comprising the inhibitor in an amount of from about 0.05 parts by mass to about 10 parts based on the total weight of the curable silicone-imide composition.

22. The curable composition of claim 17 , comprising the inhibitor in an amount of from about 0.05 parts by mass to about 2 parts based on the total weight of the curable silicone-imide composition.

23. The curable composition of claim 1 , wherein the filler (F) is selected from SiO 2 , TiO 2 , MgO, ZnO, CaCO 3 , CeO 2 , Fe 2 O 3 , SiC, Clay Material, Graphene Oxide, Boron Oxide, BN, Carbon Nano Tube, Zirconium Oxide, Fly Ash, Zr(OEt) 4 , Ti(OEt) 4 , a powder form of any Polyimide, Polybenzimidazole, Polyamideimide, Poly BPA Sulfone, Siloxane-Polyimide, Siloxane-Benzimidazole, Siloxane-Polysulfones, a combination of two or more thereof.

24. The curable composition of claim 22 , wherein the filler (F) is Fe 2 O 3 .

25. The curable composition of claim 1 , wherein the filler (F) is present in an amount of from about 0 parts by mass to about 100 parts based on the total weight of the curable silicone composition.

26. The curable composition of claim 22 , wherein the filler (F) is present in an amount of from about 20 parts by mass to about 30 parts based on the total weight of the curable silicone composition.

27. A process of preparing a cured silicone-imide material comprising contacting the composition of claim 1 with a curing condition.

28. The process as claimed in claim 27 where the curing condition is the curing catalyst.

29. A cured silicone-imide material formed from the composition of claim 1 .

30. The cured silicone-imide material of claim 28 having a thermal degradation of 300° C. to 600° C. as measured by thermogravimetric analysis at a heating rate of 10° C./min until the temperature reaches 1000° C.

31. The cured material of claim 28 , wherein the cured silicone-imide material is employed on or as part of an article in an aerospace device, an electronic device, an electronic component, an automobile, insulation, a coating, or a solvent resistant membrane.

32. An article comprising a substrate, wherein the substrate comprises the silicone-imide composition of claim 1 disposed on a surface thereof.

33. The article of claim 31 , wherein the substrate comprises a material selected from a plastic material, a ceramic, a glass, a rubber material, a filled metal, a metal alloy, a metallized plastic, a coated or painted metal, or a combination of two or more thereof.

34. The article of claim 32 , wherein the substrate material is selected from an acrylic polymer, a polyester, a polyamide, a polyimide, an acrylonitrile-styrene copolymer, a styrene-acrylonitrile-butadiene terpolymer, polyvinyl chloride, polyethylene, polycarbonate, a copolycarbonate, or a combination of two or more thereof.

35. The composition of claim 1 , wherein the composition is free of a solvent.

Assignments (5)
RELEASE OF SECURITY INTEREST IN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (063213/0472) Recorded Oct 22, 2025
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: MOMENTIVE PERFORMANCE MATERIALS INC.
Reel/Frame 073168/0715 →
RELEASE OF SECURITY INTEREST Recorded Jul 18, 2025
From: KOOKMIN BANK NEW YORK BRANCH
To: MOMENTIVE PERFORMANCE MATERIALS INC.
Reel/Frame 072039/0906 →
FIRST LIEN TERM LOAN PATENT SECURITY AGREEMENT Recorded Mar 31, 2023
From: MOMENTIVE PERFORMANCE MATERIALS INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 063213/0472 →
SECURITY INTEREST Recorded Mar 30, 2023
From: MOMENTIVE PERFORMANCE MATERIALS INC.
To: KOOKMIN BANK NEW YORK BRANCH
Reel/Frame 063197/0475 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2021
From: MANDAL, SUBRATA; FUJIMOTO, TETSUO; RAJENDRA, VINODH; ZAMPELLA, JOSEPH; NARAYANAN, RAMASUBRAMANIAN; MILLER, CLARISSA
To: MOMENTIVE PERFORMANCE MATERIALS INC.
Reel/Frame 055846/0557 →
Continuity (1)
Related Publication 20220195124A1 · Jun 23, 2022